These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 8551999)

  • 1. Behavioral and neurochemical effects of chronic methylenedioxymethamphetamine (MDMA) treatment in rhesus monkeys.
    Frederick DL; Ali SF; Slikker W; Gillam MP; Allen RR; Paule MG
    Neurotoxicol Teratol; 1995; 17(5):531-43. PubMed ID: 8551999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute effects of dexfenfluramine (d-FEN) and methylenedioxymethamphetamine (MDMA) before and after short-course, high-dose treatment.
    Frederick DL; Ali SF; Gillam MP; Gossett J; Slikker W; Paule MG
    Ann N Y Acad Sci; 1998 May; 844():183-90. PubMed ID: 9668676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral administration of 3,4-methylenedioxymethamphetamine (MDMA) produces selective serotonergic depletion in the nonhuman primate.
    Ali SF; Newport GD; Scallet AC; Binienda Z; Ferguson SA; Bailey JR; Paule MG; Slikker W
    Neurotoxicol Teratol; 1993; 15(2):91-6. PubMed ID: 7685472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurochemical and neurohistological alterations in the rat and monkey produced by orally administered methylenedioxymethamphetamine (MDMA).
    Slikker W; Ali SF; Scallet AC; Frith CH; Newport GD; Bailey JR
    Toxicol Appl Pharmacol; 1988 Jul; 94(3):448-57. PubMed ID: 2456631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral and neurochemical consequences of long-term intravenous self-administration of MDMA and its enantiomers by rhesus monkeys.
    Fantegrossi WE; Woolverton WL; Kilbourn M; Sherman P; Yuan J; Hatzidimitriou G; Ricaurte GA; Woods JH; Winger G
    Neuropsychopharmacology; 2004 Jul; 29(7):1270-81. PubMed ID: 15039771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of GBR 12909 and fluoxetine on the acute and long term changes induced by MDMA ('ecstasy') on the 5-HT and dopamine concentrations in mouse brain.
    O'Shea E; Esteban B; Camarero J; Green AR; Colado MI
    Neuropharmacology; 2001; 40(1):65-74. PubMed ID: 11077072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on monoamines in rat caudate.
    Gough B; Ali SF; Slikker W; Holson RR
    Pharmacol Biochem Behav; 1991 Jul; 39(3):619-23. PubMed ID: 1723797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lasting effects of (+-)-3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: neurochemical observations.
    Ricaurte GA; Martello AL; Katz JL; Martello MB
    J Pharmacol Exp Ther; 1992 May; 261(2):616-22. PubMed ID: 1374470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3,4-Methylenedioxymethamphetamine induces monoamine release, but not toxicity, when administered centrally at a concentration occurring following a peripherally injected neurotoxic dose.
    Esteban B; O'Shea E; Camarero J; Sanchez V; Green AR; Colado MI
    Psychopharmacology (Berl); 2001 Mar; 154(3):251-60. PubMed ID: 11351932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute effects of methylenedioxymethamphetamine (MDMA) on several complex brain functions in monkeys.
    Frederick DL; Gillam MP; Allen RR; Paule MG
    Pharmacol Biochem Behav; 1995; 51(2-3):301-7. PubMed ID: 7667344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3,4-Methylenedioxymethamphetamine ("ecstasy") selectively destroys brain serotonin terminals in rhesus monkeys.
    Insel TR; Battaglia G; Johannessen JN; Marra S; De Souza EB
    J Pharmacol Exp Ther; 1989 Jun; 249(3):713-20. PubMed ID: 2471824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute Effects of Dexfenfluramine (d-FEN) and Methylenedioxymethamphetamine (MDMA) before and after Short-Course, High-Dose Treatment.
    Frederick DL; Ali SF; Gillam MP; Gossett J; Slikker W; Paule MG
    Ann N Y Acad Sci; 1998 May; 844(1):183-190. PubMed ID: 29090816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral and neurochemical effects of orally administered MDMA in the rodent and nonhuman primate.
    Slikker W; Holson RR; Ali SF; Kolta MG; Paule MG; Scallet AC; McMillan DE; Bailey JR; Hong JS; Scalzo FM
    Neurotoxicology; 1989; 10(3):529-42. PubMed ID: 2576304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethanol, 3,4-methylenedioxymethamphetamine (ecstasy) and their combination: long-term behavioral, neurochemical and neuropharmacological effects in the rat.
    Cassel JC; Riegert C; Rutz S; Koenig J; Rothmaier K; Cosquer B; Lazarus C; Birthelmer A; Jeltsch H; Jones BC; Jackisch R
    Neuropsychopharmacology; 2005 Oct; 30(10):1870-82. PubMed ID: 15785779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the abuse potential of MDMA in the conditioned place preference paradigm: role of CB1 receptors.
    Rodríguez-Arias M; Valverde O; Daza-Losada M; Blanco-Gandía MC; Aguilar MA; Miñarro J
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():77-84. PubMed ID: 23959085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effects of substituted amphetamines (PMA, MDMA, and METH) on monoamines in rat caudate: a microdialysis study.
    Gough B; Imam SZ; Blough B; Slikker W; Ali SF
    Ann N Y Acad Sci; 2002 Jun; 965():410-20. PubMed ID: 12105116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term central 5-HT depletions resulting from repeated administration of MDMA enhances the effects of single administration of MDMA on schedule-controlled behavior of rats.
    Li AA; Marek GJ; Vosmer G; Seiden LS
    Pharmacol Biochem Behav; 1989 Jul; 33(3):641-8. PubMed ID: 2573905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of repeated ('binge') dosing of MDMA to rats housed at normal and high temperature on neurotoxic damage to cerebral 5-HT and dopamine neurones.
    Sanchez V; O'shea E; Saadat KS; Elliott JM; Colado MI; Green AR
    J Psychopharmacol; 2004 Sep; 18(3):412-6. PubMed ID: 15358986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein.
    Wang X; Baumann MH; Xu H; Rothman RB
    Synapse; 2004 Sep; 53(4):240-8. PubMed ID: 15266556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive performance of MDMA-treated rhesus monkeys: sensitivity to serotonergic challenge.
    Taffe MA; Davis SA; Yuan J; Schroeder R; Hatzidimitriou G; Parsons LH; Ricaurte GA; Gold LH
    Neuropsychopharmacology; 2002 Dec; 27(6):993-1005. PubMed ID: 12464456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.